FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vincent Ribrag

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Martin Dreyling; Olivier Hermine; Georg Hess; Eva Hoster; Grit Hutter; Wolfram Klapper; Pavel Klener; Hanneke C Kluin-Nelemans; Christiane Pott; Vincent Ribrag; Michael Unterhalt; Carlo Visco; Umberto Vitolo; Niclas Vogt; Igor Aurer; Sílvia Beà; Chan Cheah; Annalisa Chiappella; Sergio Cortelazzo; Marie-Helene Delfau-Larue
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Krimo Bouabdallah; Vincent Ribrag; Jean-Charles Soria; Louis Terriou; Richard Delarue
Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects.
Vincent Ribrag; Hervé Tilly; André Bosly; Reda Bouabdallah; François Boue; Dominique Bron; Olivier Casasnovas; Richard Delarue; Pierre Feugier; Corinne Haioun; Firtz Offner; Bertrand Coiffier
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vincent Ribrag (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Dreyling; Olivier Hermine; Georg Hess; Eva Hoster; Grit Hutter; Wolfram Klapper; Pavel Klener; Hanneke C Kluin-Nelemans; Christiane Pott; Vincent Ribrag; Michael Unterhalt; Carlo Visco; Umberto Vitolo; Niclas Vogt; Igor Aurer; Sílvia Beà; Chan Cheah; Annalisa Chiappella; Sergio Cortelazzo; Marie-Helene Delfau-Larue
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Leukemia & lymphoma 2013;54(4):699-707.
2013: Krimo Bouabdallah; Vincent Ribrag; Jean-Charles Soria; Louis Terriou; Richard Delarue
Temsirolimus in the treatment of mantle cell lymphoma: frequency and management of adverse effects.
Current opinion in oncology 2013;25 Suppl 2():S1-12.
2013: Vincent Ribrag; Hervé Tilly; André Bosly; Reda Bouabdallah; François Boue; Dominique Bron; Olivier Casasnovas; Richard Delarue; Pierre Feugier; Corinne Haioun; Firtz Offner; Bertrand Coiffier
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
European journal of cancer (Oxford, England : 1990) 2013;49(4):904-10.
2013: Vincent Ribrag; Gilles Salles; Sergio Szyldergemajn; Emanuele Zucca; Reyes Arranz; Javier Briones; Dolores Caballero; Claudia Corrado; Martin Cullell-Young; Bernardo de Miguel; Sonia Extremera; Christophe Fermé; Alessandro M Gianni; Christian Gisselbrecht; Henry Gomez; Carmen Kahatt; Franco Cavalli
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.
Haematologica 2013;98(3):357-63.
2013: Richard Delarue; Alain Delmer; Corinne Haioun; Olivier Hermine; Francois Lefrere; Vincent Ribrag; Gilles SALLES; Herve Tilly; Achiel Van Hoof; Pauline Brice; Nicole Brousse; Olivier Casasnovas
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.
Blood 2013;121(1):48-53.
2013: Etienne Crickx; Alina Danu; Stéphane de Botton; Francois Boué; Jean-Henri Bourhis; Xavier Mariette; Corinne Miceli; Philippe Moreau; Florence Pasquier; Vincent Ribrag; Sebastian Wittnebel; David Ghez
Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis.
European journal of cancer (Oxford, England : 1990) 2013;49(2):411-5.
2013: Bénédicte Deau; Richard Delarue; Olivier Hermine; Vincent Ribrag; Marie Thérèse Rubio; Bruno Varet; Emmanuel Bachy; Jacques Bosq; Nicole Brousse; Danielle Canioni
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.
Leukemia & lymphoma 2013;54(1):41-5.
2012: Valérie Camara-Clayette; Olivier Hermine; Vincent Ribrag
Emerging agents for the treatment of mantle cell lymphoma.
Expert review of anticancer therapy 2012;12(9):1205-15.
2012: Theodore Girinsky; Colette Hanna; François Leroy-Ladurie; Amaury Paumier; Vincent Ribrag; Christophe Ferme; Mithra Ghalibafian
Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients.
International journal of radiation oncology, biology, physics 2012;83(3):e385-9.
2011: Martin Dreyling; Steven Le Gouill; Elena Hartmann; Olivier Hermine; Georg Hess; Eva Hoster; Grit Hutter; Hanneke C Kluin-Nelemans; Patricia Perez-Galan; Christiane Pott; Vincent Ribrag; Gael Roue; Simon Rule; Itziar Salaverria; Michal Szymczyk; Michael Unterhalt; Umberto Vitolo; Jan Walewski; Francesco Zaja; Sílvia Beà; Sergio Cortelazzo
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
Leukemia & lymphoma 2011;52(12):2226-36.
2011: Carlos Gomez-Roca; Serge Koscielny; Inès Marzouk; Christophe Massard; Vincent Ribrag; Ratislav Bahleda; François Bidault; Clarisse Dromain; Charles Ferté; Jean-Charles Soria
Tumour growth rates and RECIST criteria in early drug development.
European journal of cancer (Oxford, England : 1990) 2011;47(17):2512-6.
2011: Stéphanie Harel; Richard Delarue; Martin Dreyling; Vincent Ribrag; Olivier Hermine
Treatment of younger patients with mantle cell lymphoma.
Seminars in hematology 2011;48(3):194-207.
2011: Didier Decaudin; Nicolas Mounier; Hervé Tilly; Vincent Ribrag; Hervé Ghesquières; Krimo Bouabdallah; Franck Morschhauser; Bertrand Coiffier; Steven Le Gouill; Serge Bologna; Richard Delarue; Anne Huynh; André Bosly; Josette Brière; Christian Gisselbrecht
(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.
Clinical lymphoma, myeloma & leukemia 2011;11(2):212-8.
2011: Laura Moise; Clemence Matta; Colette Hanna; Sylvain Pilorge; Christophe Fermé; Antoine Durrbach; Vincent Ribrag
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Leukemia & lymphoma 2011;52(3):521-4.
2011: Sophie Viaud; Caroline Flament; Mustapha Zoubir; Patricia Pautier; Axel LeCesne; Vincent Ribrag; Jean-Charles Soria; Virginie Marty; Philippe Vielh; Caroline Robert; Nathalie Chaput; Laurence Zitvogel
Cyclophosphamide induces differentiation of Th17 cells in cancer patients.
Cancer research 2011;71(3):661-5.
2010: Martin Dreyling; Eva Hoster; Silvia Bea; Elena Hartmann; Heike Horn; Grit Hutter; Itziar Salaverria; Christiane Pott; Marek Trneny; Steven Le Gouill; Sergio Cortelazzo; Michal Szymczyk; Wojciech Jurczak; Ofer Shpilberg; Vincent Ribrag; Olivier Hermine
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
Leukemia & lymphoma 2010;51(9):1612-22.
2010: Delphine Rolland; Vincent Ribrag; Corinne Haioun; Herve Ghesquieres; Fabrice Jardin; Reda Bouabdallah; Patricia Franchi; Josette Briere; Eric de Kerviler; Catherine Chassagne-Clement; Mitch Raponi; Remi Houlgatte; Jean-Philippe jais; Catherine Thieblemont
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.
Cancer chemotherapy and pharmacology 2010;65(4):781-90.
2009: Bertrand Coiffier; Vincent Ribrag
Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignancies.
Leukemia & lymphoma 2009;50(12):1916-30.
2009: Vincent Ribrag; Christian Gisselbrecht; Corinne Haioun; Gilles SALLES; Jean-Baptiste Golfier; Marjan Ertault; Christophe Ferme; Josette Briere; Pauline Brice; Nicolas Mounier
Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Cancer 2009;115(19):4540-6.
2009: Vincent Ribrag; serge koscielny; Olivier Casasnovas; Cecile Cazeneuve; Pauline Brice; Franck Morschhauser; Jean Gabarre; Aspasia Stamatoullas; Gilbert Lenoir; Gilles SALLES
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Blood 2009;113(14):3307-13.
2009: Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain BERNHEIM
High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.
PloS one 2009;4(9):e7089.
2009: Danielle Canioni; Bénédicte Deau-Fischer; Pierre Taupin; Vincent Ribrag; Richard Delarue; Jacques Bosq; Marie-Thérèse Rubio; Damien Roux; Viorel Vasiliu; Bruno Varet; Nicole Brousse; Olivier Hermine
Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.
PloS one 2009;4(7):e6341.
2008: Marcel Massoud; serge koscielny; Simona Lapusan; Jacques Bosq; Vincent Ribrag
Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy.
Leukemia & lymphoma 2008;49(8):1510-5.
2008: Vincent Ribrag; Daniel Vanel; sophie leboulleux; Jean Lumbroso; Dominique Couanet; Guillaume Bonniaud; Anne Aupérin; Florence Masson; Jacques Bosq; Véronique Edeline; Christophe Fermé; Frédéric Pigneur; Martin Schlumberger
Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
European journal of radiology 2008;66(2):325-31.
2008: Delphine Rolland; Valérie Camara-Clayette; Aurélie Barbarat; Gilles SALLES; Bertrand Coiffier; Vincent Ribrag; Catherine Thieblemont
Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.
Cancer chemotherapy and pharmacology 2008;61(5):855-63.
2007: Patricia Pautier; Vincent Ribrag; Pierre Duvillard; Annie Rey; I Elghissassi; I Sillet-Bach; Pierre Kerbrat; F Mayer; Anne Lesoin; B Brun; H Crouet; Jean-Claude Barats; Philippe Morice; Catherine Lhommé
Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1985-9.
2007: Jérémy Coulot; Valérie Camara-Clayette; Marcel Ricard; Frédéric Lavielle; Valérie Velasco; Françoise Drusch; Jacques Bosq; Martin Schlumberger; Vincent Ribrag
Imaging of the distribution of (90)y-ibritumomab tiuxetan in bone marrow and comparison with pathology.
Cancer biotherapy & radiopharmaceuticals 2007;22(5):665-71.
2007: Magda Pinyol; Silvia Bea; Laura Plà; Vincent Ribrag; Jacques Bosq; Andreas Rosenwald; Elias Campo; Pedro Jares
Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.
Blood 2007;109(12):5422-9.
2007: Jean-Pierre Armand; Vincent Ribrag; Jean-Luc Harrousseau; Lauren E Abrey
Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.
Therapeutics and clinical risk management 2007;3(2):213-24.
2007: Radhia M'kacher; Annelise Bennaceur-Griscelli; Theodore Girinsky; serge koscielny; François Delhommeau; Julien Dossou; Dominique Violot; Evelyne Leclercq; Marie Hélène Courtier; Nadine Béron-Gaillard; Elias Assaf; Vincent Ribrag; Jean Bourhis; Danielle Feneux; Alain BERNHEIM; Claude Parmentier; Patrice Carde
Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
International journal of radiation oncology, biology, physics 2007;68(2):465-71.
2007: Catherine Patte; Vincent Ribrag; Laurence Brugières
[Non Hodgkin's lymphoma in adolescents].
Bulletin du cancer 2007;94(4):339-48.
2007: Céline Bossard; Karim Belhadj; Felix Reyes; Nadine Martin-Garcia; Françoise Berger; Jean Alain Kummer; Josette Brière; Anne-Catherine Baglin; Stéphane Cheze; Jacques Bosq; Vincent Ribrag; Christian Gisselbrecht; Nicolas Mounier; Philippe Gaulard
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Blood 2007;109(5):2183-9.
2007: Sophie Queille; Lionel Luron; Alain Spatz; Marie-Françoise Avril; Vincent Ribrag; Pierre Duvillard; Christian Hiesse; Alain Sarasin; Jean-Pierre Armand; Leela Daya-Grosjean
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
Carcinogenesis 2007;28(3):724-31.
2007: Anna Berceanu; Saloua Toujani; Lydie Da Costa; Nathalie Itzhar; Simona Lapusan; Alain BERNHEIM; Vincent Ribrag
An unusual case of a lymphoblastic lymphoma with initial bilateral breast lesions but with c-myc and bcl-2 rearrangements.
Leukemia & lymphoma 2007;48(2):415-7.
2007: yves lepelletier; Valérie Camara-Clayette; Hulin Jin; Aurélie Hermant; Séverine Coulon; Michaël Dussiot; Michelle Arcos-Fajardo; Cédric Baude; Danielle Canionni; Richard Delarue; Nicole Brousse; Philippe Benaroch; Marc Benhamou; Vincent Ribrag; Renato C Monteiro; Ivan C Moura; Olivier Hermine
Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.
Cancer research 2007;67(3):1145-54.
2006: Norbert Vey; André Bosly; Agnès Guerci; Walter Feremans; Hervé Dombret; François Dreyfus; David Bowen; Alan Burnett; Mike Dennis; Vincent Ribrag; Nicole Casadevall; Laurence Legros; Pierre Fenaux
Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2465-71.
2006: E Jabbour; serge koscielny; Catherine Sebban; N Peslin; Catherine Patte; T Gargi; P Biron; Christophe Fermé; Jean-Henri Bourhis; Jean-Marie Vantelon; P Arnaud; Vincent Ribrag
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL).
Leukemia 2006;20(5):814-9.
2006: Thorsten Braun; Gabrielle Carvalho; Arnaud Coquelle; Marie-Catherine Vozenin; Pascale Lepelley; François Hirsch; Jean-Jacques Kiladjian; Vincent Ribrag; Pierre Fenaux; Guido Kroemer
NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome.
Blood 2006;107(3):1156-65.
2005: Marine Diviné; Philippe Casassus; serge koscielny; Jacques Bosq; Catherine Sebban; Christine Le Maignan; A Stamattoulas; Brigitte Dupriez; Martine Raphaël; José-Luis Pico; Vincent Ribrag
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1928-35.
2005: C Oprea; C Cainap; R Azoulay; E Assaf; E Jabbour; serge koscielny; Simona Lapusan; D Vanel; Jacques Bosq; Vincent Ribrag
Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases.
British journal of haematology 2005;131(4):468-71.
2005: E Jabbour; N Peslin; P Arnaud; Christophe Ferme; Patrice Carde; J M Vantelon; C Bocaccio; J H Bourhis; serge koscielny; Vincent Ribrag
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Leukemia & lymphoma 2005;46(6):861-7.
2005: Theodore Girinsky; Simona Lapusan; Vincent Ribrag; serge koscielny; Christophe Ferme; Patrice Carde
Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
International journal of radiation oncology, biology, physics 2005;61(2):476-9.
2005: Christophe Fermé; Daniel Vanel; Vincent Ribrag; Théo Girinski
Role of imaging to choose treatment.
Cancer imaging : the official publication of the International Cancer Imaging Society 2005;5 Spec No A():S113-9.
2005: E Jabbour; Vincent Ribrag
[Acute tumor lysis syndrome: update on therapy].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(1):27-32.
2004: Nicole Casadevall; Pierre Durieux; Stéphanie Dubois; François Hemery; Eric Lepage; Marie-Catherine Quarré; Gandhi Damaj; Stéphane Giraudier; Agnès Guerci; Guy Laurent; Hervé Dombret; Christine Chomienne; Vincent Ribrag; Aspasia Stamatoullas; Jean-Pierre Marie; Anne Vekhoff; Frédéric Maloisel; Robert Navarro; François Dreyfus; Pierre Fenaux
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.
Blood 2004;104(2):321-7.
2004: E Jabbour; B Chalhoub; Florence Suzan; Samir Aloulou; C Cainap; N Toumi; Christophe Fermé; Patrice Carde; Vincent Ribrag
Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.
Leukemia & lymphoma 2004;45(7):1391-4.
2004: Annelise Bennaceur-Griscelli; Jacques Bosq; serge koscielny; François Lefrère; Ali G Turhan; Nicole Brousse; Olivier Hermine; Vincent Ribrag
High level of glutathione-S-transferase pi expression in mantle cell lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3029-34.
2003: Radhia M'kacher; Theodore Girinsky; serge koscielny; Julien Dossou; Dominique Violot; Nadine Béron-Gaillard; Vincent Ribrag; Jean Bourhis; Alain BERNHEIM; Claude Parmentier; Patrice Carde
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients.
International journal of radiation oncology, biology, physics 2003;57(2):321-6.
2003: Radhia M'kacher; Annelise Bennaceur; Françoise Farace; A Laugé; L F Plassa; E Wittmer; Julien Dossou; Dominique Violot; Eric Deutsch; Jean Bourhis; D Stoppa-Lyonnet; Vincent Ribrag; Patrice Carde; Claude Parmentier; Alain BERNHEIM; Ali G Turhan
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
Oncogene 2003;22(39):7905-12.
2003: Vincent Ribrag; serge koscielny; Jean-Marie Vantelon; Christophe Fermé; K Rideller; Patrice Carde; Jean-Henri Bourhis; Jean-Nicolas Munck
Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomas.
Leukemia & lymphoma 2003;44(9):1529-33.
2003: Dany Gholam; F Bibeau; A El Weshi; Jacques Bosq; Vincent Ribrag
Primary breast lymphoma.
Leukemia & lymphoma 2003;44(7):1173-8.
2003: Vincent Ribrag; serge koscielny; I Carpiuc; C Cebotaru; H Vande Walle; M Talbot; Pierre Fenaux; Jacques Bosq
Prognostic value of GST-pi expression in diffuse large B-cell lymphomas.
Leukemia 2003;17(5):972-7.
2003: Radhia M'kacher; Françoise Farace; Annelise Bennaceur-Griscelli; Dominique Violot; Bernard Clausse; Julien Dossou; Alexander Valent; Claude Parmentier; Vincent Ribrag; Jacques Bosq; Patrice Carde; Ali G Turhan; Alain BERNHEIM
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.
Cancer genetics and cytogenetics 2003;143(1):32-8.
2003: Reda Bouabdallah; Nicolas Mounier; C Guettier; T Molina; Vincent Ribrag; Catherine Thieblemont; Anne Sonet; Alain Delmer; Karim Belhadj; Philippe Gaulard; Christian Gisselbrecht; Luc Xerri
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1271-7.
2003: Vincent Ribrag; Florence Suzan; C Ravoet; Walter Feremans; Agnès Guerci; François Dreyfus; Gandhi Damaj; Jean-Marie Vantelon; Jean-Henri Bourhis; Pierre Fenaux
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.
Leukemia 2003;17(2):319-22.
2002: Samir Aloulou; Jacques Bosq; Daniel Vanel; Vincent Ribrag
Unusual sites of involvement in non-Hodgkin's lymphoma: Case 2. Isolated meningeal anaplastic large-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4395-7.
2002: I Carpiuc; Sami Antoun; A Delabarthe; B Driss; Jean-Marie Vantelon; Frank Griscelli; R Fenaux; Vincent Ribrag
Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome.
Leukemia & lymphoma 2002;43(8):1701-3.
2002: François Lefrère; Alain Delmer; Florence Suzan; HADJ SLIMANE MEHDI; Coralie Belanger; M Djabarri; Bertrand Arnulf; Gandhi Damaj; Natacha Maillard; Vincent Ribrag; Maud Janvier; Catherine Sebban; René-Olivier Casasnovas; Reda Bouabdallah; François Dreyfus; Virginie Verkarre; Eric Delabesse; Françoise Valensi; Elizabeth McIntyre; Nicole Brousse; Bruno Varet; Olivier Hermine
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.
Leukemia 2002;16(4):587-93.
2002: D Kerob; Jean-Marie Vantelon; Vincent Ribrag; Jacques Bosq; Eric Desruennes; Jean-Henri Bourhis; Marie-Françoise Avril
[Cutaneous localization of multiple myeloma on the tract of a central venous catheter].
Annales de dermatologie et de vénéréologie 2002;129(3):311-4.
2002: Samir Aloulou; Hassan Farhat; Jacques Bosq; Daniel Vanel; Vincent Ribrag; Ali G Turhan; Theodore Girinsky; Christophe Fermé
Hodgkin's disease primarily involving the oropharynx: case report and review of the literature.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(3):164-7.
2001: Vincent Ribrag; F Bibeau; A El Weshi; J Frayfer; C Fadel; C Cebotaru; K Laribi; Pierre Fenaux
Primary breast lymphoma: a report of 20 cases.
British journal of haematology 2001;115(2):253-6.
2001: Theodore Girinsky; D Guillot-Vals; serge koscielny; Jean-Marc Cosset; Gérard Ganem; Patrice Carde; M Monhonval; R Pereira; Jacques Bosq; Vincent Ribrag; Jean-Marie Vantelon; Jean-Nicolas Munck
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment.
International journal of radiation oncology, biology, physics 2001;51(1):148-55.
2001: Vincent Ribrag; M Ell Hajj; François Janot; Theodore Girinsky; Christian Domenge; Guy Schwaab; Pierre Fenaux; Jacques Bosq
Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.
Leukemia 2001;15(7):1123-6.
2001: Jean-Marie Vantelon; Jean-Nicolas Munck; Jean-Henri Bourhis; José-Luis Pico; C Fadel; Ayhan Ulusakarya; Patrice Carde; Pierre Fenaux; Vincent Ribrag
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.
Bone marrow transplantation 2001;27(5):531-6.
2001: P Fenaux; Jean-Henri Bourhis; Vincent Ribrag
Burkitt's acute lymphocytic leukemia (L3ALL) in adults.
Hematology/oncology clinics of North America 2001;15(1):37-50.
2001: Carole Soussain; Florence Suzan; Khê Hoang-Xuan; N Cassoux; HADJ SLIMANE MEHDI; N Azar; Coralie Belanger; E Achour; Vincent Ribrag; S Gerber; J Y Delattre; Véronique Leblond
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):742-9.
2000: Jean-Marie Vantelon; serge koscielny; Philippe Brault; Jean-Henri Bourhis; Vincent Ribrag; José-Luis Pico; Pierre Fenaux; Jean-Nicolas Munck
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.
Bone marrow transplantation 2000;25(5):495-9.
1998: A El Weshi; Vincent Ribrag; Théo Girinski; M El Hajj; F Dhermain; Chantal Bayle
Low and medium dose spleen radiation therapy are able to induce long-term responses in splenic lymphoma with villous lymphocytes.
British journal of haematology 1998;103(4):1212-3.
1998: L Castagna; A El Weshi; Jean-Henri Bourhis; Vincent Ribrag; P Naccache; Jean-Marie Vantelon; Philippe Brault; José-Luis Pico
Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT)
British journal of haematology 1998;103(1):284-5.
1998: Vincent Ribrag; F Nasr; J H Bouhris; Jacques Bosq; Philippe Brault; Theodore Girinsky; Jean-Marc Cosset; Jean-Nicolas Munck; C Corti; Didier Decaudin; José-Luis Pico; M Hayat; Patrice Carde
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.
Bone marrow transplantation 1998;21(10):969-74.
1998: L Kepka; A De Lassence; Vincent Ribrag; Bertrand Gachot; François Blot; Christine Theodore; Marc Bonnay; C Korenbaum; Gérard Nitenberg
Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure.
Leukemia & lymphoma 1998;29(1-2):205-9.
1997: L Massaad-Massade; Vincent Ribrag; Jean-Pierre Marie; Anne-Marie Faussat; Chantal Bayle; François Dreyfus; Alain Gouyette
Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Anticancer research 1997;17(6D):4647-51.
1997: Didier Decaudin; Jacques Bosq; Jean-Nicolas Munck; Chantal Bayle; serge koscielny; S Boudjemaa; Annelise Bennaceur; AM Venuat; P Naccache; B Bendahmane; Vincent Ribrag; Patrice Carde; José-Luis Pico; M Hayat
Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 cases.
Leukemia & lymphoma 1997;26(5-6):539-50.
1997: F Nasr; Elizabeth Macintyre; AM Venuat; Chantal Bayle; Patrice Carde; Vincent Ribrag
Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.
Leukemia & lymphoma 1997;25(3-4):399-401.
1996: C Corti; Christine Theodore; Chantal Bayle; P Rougier; F Nasr; Jean-Marc Cosset; Theodore Girinsky; M Hayat; Vincent Ribrag
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Hematological oncology 1996;14(4):159-63.
1996: Vincent Ribrag; L Massade; Anne-Marie Faussat; F Dreyfus; Chantal Bayle; Alain Gouyette; Jean-Pierre Marie
Drug resistance mechanisms in chronic lymphocytic leukemia.
Leukemia 1996;10(12):1944-9.
1996: F Nasr; C Corti; Patrice Carde; Vincent Ribrag; F Valensi; C Bayle; Ali G Turhan; Jacques Bosq
Carcinoma cell leukemia.
Blood 1996;88(6):2355-7.
1996: R Tordjman; Elizabeth Macintyre; J F Emile; Françoise Valensi; Vincent Ribrag; M L Burtin; Bruno Varet; Nicole Brousse; Olivier Hermine
Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest.
Leukemia 1996;10(9):1514-9.
1996: A Buzyn-Veil; Coralie Belanger; Françoise Audat; Olivier Hermine; Christine Bodemer; Vincent Ribrag; I Radford; H Poirel; C Chane; Françoise Valensi; Elizabeth Macintyre; Bruno Varet
Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantation.
British journal of haematology 1996;92(2):423-5.
1995: Jean Gabarre; Eric Lepage; A Thyss; R Tubiana; Y Bastion; daniel schlaifer; C Sebban; Vincent Ribrag; M Fereres; M Raphael
Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):1025-32.
1995: Philippe Brault; Erard Gilles; Vincent Ribrag; J H Bourhis; Jean-Nicolas Munck; José-Luis Pico; M Hayat
[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)].
Bulletin du cancer 1995;82(12):1032-7.
1995: Vincent Ribrag; L Massaad; François Janot; Jackie Morizet; Alain Gouyette; Guy G. Chabot
Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy.
Leukemia & lymphoma 1995;18(3-4):303-10.
1995: François Dreyfus; Vincent Ribrag; Véronique Leblond; Philippe Ravaud; Josiane Melle; M C Quarre; C Pillier; C Boccaccio; Bruno Varet
Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma.
Bone marrow transplantation 1995;15(5):707-11.
1995: Didier Bouscary; C Preudhomme; Vincent Ribrag; Josiane Melle; Franck Viguié; Françoise Picard; Martine Guesnu; P Fenaux; Sylvie Gisselbrecht; François Dreyfus
Prognostic value of c-mpl expression in myelodysplastic syndromes.
Leukemia 1995;9(5):783-8.
1995: François Dreyfus; Didier Bouscary; Josiane Melle; Vincent Ribrag; Martine Guesnu; Bruno Varet
Expression of the Evi-1 gene in myelodysplastic syndromes.
Leukemia 1995;9(1):203-5.
1994: Vincent Ribrag; L Massaad; François Janot; MC Bissery; O Parise; Alain Gouyette; Guy G. Chabot
Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo.
Leukemia research 1994;18(11):829-35.
1993: Vincent Ribrag; D Salmon; F Picard; Martine Guesnu; D Sicard; F Dreyfus
Increase in double-positive CD4+CD8+ peripheral T-cell subsets in an HIV-infected patient.
AIDS (London, England) 1993;7(11):1530.
1993: Vincent Ribrag; J P Droz; Jackie Morizet; B Leclercq; Alain Gouyette; Guy G. Chabot
Test dose-guided administration of cisplatin in an anephric patient: a case report.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):679-82.
1993: I Vigon; François Dreyfus; Josiane Melle; Franck Viguié; Vincent Ribrag; L Cocault; M Souyri; Sylvie Gisselbrecht
Expression of the c-mpl proto-oncogene in human hematologic malignancies.
Blood 1993;82(3):877-83.
1993: François Janot; L Massaad; Vincent Ribrag; I de Waziers; Philippe Beaune; Bernard Luboinski; O Parise; Alain Gouyette; Guy G. Chabot
Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma.
Carcinogenesis 1993;14(7):1279-83.
1993: Vincent Ribrag; François Dreyfus; Alain Venot; V Leblong; J J Lanore; Bruno Varet
Prognostic factors of invasive pulmonary aspergillosis in leukemic patients.
Leukemia & lymphoma 1993;10(4-5):317-21.
1993: L Massaad; I de Waziers; Vincent Ribrag; François Janot; Jackie Morizet; Philippe Beaune; Alain Gouyette; Guy G. Chabot
[Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors].
Bulletin du cancer 1993;80(5):397-407.
1993: E Rouer; François Dreyfus; Josiane Melle; Vincent Ribrag; Richard Benarous
Selective increase of alternatively spliced Lck transcripts from the proximal promotor in hematopoietic malignancies.
Leukemia 1993;7(2):246-50.
1992: L Massaad; I de Waziers; Vincent Ribrag; François Janot; Philippe Beaune; Jackie Morizet; Alain Gouyette; Guy G. Chabot
Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
Cancer research 1992;52(23):6567-75.
1992: François Dreyfus; Véronique Leblond; Coralie Belanger; Jean Gabarre; Laurent Sutton; C Boccaccio; M C Quarre; Vincent Ribrag; A Goy
Peripheral blood stem cell collection and autografting in high risk lymphomas.
Bone marrow transplantation 1992;10(5):409-13.
1992: Joseph Kattan; Jean Pierre Droz; Vincent Ribrag; M Azab; A Boutan-Laroze; Antoine Andremont
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):867-70.
1992: Joseph Kattan; Jean Pierre Droz; Stéphane Culine; Vincent Ribrag; A Boutan-Laroze; Antoine Andremont
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Bulletin du cancer 1992;79(7):705-12.
1992: Vincent Ribrag; Jean Pierre Droz; Joseph Kattan; Antoine Andremont
Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors.
Bulletin du cancer 1992;79(5):491-5.
1992: Vincent Ribrag; Chantal Bayle; Philippe Brault; S Bodis; E Magherini; M Hayat
Acute myelogenous leukemia with T-cell features.
Bulletin du cancer 1992;79(12):1165-71.
1990: Vincent Ribrag; Jean Pierre Droz; C Bouleuc; Christine Theodore; Marwan Ghosn; José-Luis Pico; M Azab; M Ostronoff; M Hayat
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].
Presse médicale (Paris, France : 1983) 1990;19(27):1263-6.
1990: Vincent Ribrag; M Ghnassia; Christine Théodore; Marwan Ghosn; G Piot; Daniel Beurton; J Cukier; Jean Pierre Droz
[Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].
Journal d'urologie 1990;96(7):373-4.
1989: Jean Pierre Droz; Vincent Ribrag; Marwan Ghosn; J Guimares; Christine Theodore; M Azab; M Ostronoff; Mondher Mahjoubi; A Moran; J Pico
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Progress in clinical and biological research 1989;303():739-47.